In CRC, for example, hypoxia-induced inflammation and altered insulin signaling pathways lead to increased insulin resistance and hyperinsulinemia, which can promote colorectal carcinogenesis through the insulin/IGF axis as stated previously [72]. The gene discussed is INS; the disease is hyperinsulinism.